ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
6 hedge funds and large institutions have $896K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
–
Calls
$252K
Puts
–
Net Calls
+$252K
Net Calls Change
-$478K
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$479K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$17K |
| 3 |
Morgan Stanley
New York
|
$3K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
$13K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
$180K |
| 2 |
Jane Street
New York
|
$204K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $479K | +$479K | +14,286 | New |
|
|
2
Jane Street
New York
| $204K | -$42.4K | -1,264 | -17% |
|
|
VF
3
Virtu Financial
New York
| $180K | -$213K | -6,349 | -54% |
|
|
4
UBS Group
Zurich,
Switzerland
| $17K | +$17K | +507 | New |
|
|
CG
5
Cutler Group
San Francisco,
California
| $13K | +$129 | +4 | +1% |
|
|
6
Morgan Stanley
New York
| $3K | +$3K | +93 | New |
|